Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance
Key facts
- Where
- Herlev, DenmarkSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT02526797, who can take part
Where in Denmark
- Department of Urology, Herlev University Hospital HerlevHerlev, DenmarkNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Herlev Hospital
- Trial code
- NCT02526797
- Record updated
- 16 September 2026
- Original description
To investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring.Read full original descriptionShow less
To investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring.
Inclusion: Patients with low risk localized prostate cancer enrolled in active surveillance.
Exclusion: Metastatic prostate cancer; Prostate cancer treatment; Known allergic reaction to Gadolinium-based MRI contrast agent; Psychiatric disorders; Impaired renal function with GFR < 30 ml / min; Age under 18 years; No mp-MRI data present; Prostate biopsy during the last 21 days; pacemaker; Magnetic metal residues in the body; Claustrophobia.